GLS and Familial prostate cancer: In this study, GLS inhibition reduced glutamine metabolism in prostate cancer cells, significantly decreasing the expression of stem cell markers (such as ALDH, OCT4, and Sox2), with the cells exhibiting reduced stemness characteristics.